95 related articles for article (PubMed ID: 12954114)
1. Inhibitory oligonucleotides block the induction of AP-1 transcription factor by stimulatory CpG oligonucleotides in B cells.
Lenert P; Yi AK; Krieg AM; Stunz LL; Ashman RF
Antisense Nucleic Acid Drug Dev; 2003; 13(3):143-50. PubMed ID: 12954114
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells.
Stunz LL; Lenert P; Peckham D; Yi AK; Haxhinasto S; Chang M; Krieg AM; Ashman RF
Eur J Immunol; 2002 May; 32(5):1212-22. PubMed ID: 11981808
[TBL] [Abstract][Full Text] [Related]
3. CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation.
Lenert P; Stunz L; YI AK; Krieg AM; Ashman RF
Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):247-56. PubMed ID: 11572601
[TBL] [Abstract][Full Text] [Related]
4. Structural characterization of the inhibitory DNA motif for the type A (D)-CpG-induced cytokine secretion and NK-cell lytic activity in mouse spleen cells.
Lenert P; Rasmussen W; Ashman RF; Ballas ZK
DNA Cell Biol; 2003 Oct; 22(10):621-31. PubMed ID: 14611683
[TBL] [Abstract][Full Text] [Related]
5. Phosphorothioate oligodeoxyribonucleotides induce in vitro proliferation of chicken B-cells.
Wattrang E
Vet Immunol Immunopathol; 2009 Oct; 131(3-4):218-28. PubMed ID: 19447503
[TBL] [Abstract][Full Text] [Related]
6. [Effects of CpG-ODN combined with HBsAg on the phenotype, function and the activity of NF-kappa B and AP-1 of monocyte-derived dendritic cells in chronic hepatitis B patients].
Xiang XX; Zhou XQ; Xie Q; Yu H; Zhou HJ
Zhonghua Gan Zang Bing Za Zhi; 2008 Feb; 16(2):97-100. PubMed ID: 18304423
[TBL] [Abstract][Full Text] [Related]
7. Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif.
Zhang Y; Shoda LK; Brayton KA; Estes DM; Palmer GH; Brown WC
J Interferon Cytokine Res; 2001 Oct; 21(10):871-81. PubMed ID: 11711000
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds.
Macfarlane DE; Manzel L
J Immunol; 1998 Feb; 160(3):1122-31. PubMed ID: 9570525
[TBL] [Abstract][Full Text] [Related]
9. Anti-proliferative effects of phosphodiester oligodeoxynucleotides.
Bjersing JL; Tarkowski A; Collins LV
Immunobiology; 2004; 209(8):637-45. PubMed ID: 15638132
[TBL] [Abstract][Full Text] [Related]
10. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
[TBL] [Abstract][Full Text] [Related]
11. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells.
Hartmann G; Battiany J; Poeck H; Wagner M; Kerkmann M; Lubenow N; Rothenfusser S; Endres S
Eur J Immunol; 2003 Jun; 33(6):1633-41. PubMed ID: 12778481
[TBL] [Abstract][Full Text] [Related]
12. The secretion of IL-6 by CpG-ODN-treated cancer cells promotes T-cell immune responses partly through the TLR-9/AP-1 pathway in oral squamous cell carcinoma.
Ruan M; Thorn K; Liu S; Li S; Yang W; Zhang C; Zhang C
Int J Oncol; 2014 Jun; 44(6):2103-10. PubMed ID: 24676671
[TBL] [Abstract][Full Text] [Related]
13. CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines.
Oxenius A; Martinic MM; Hengartner H; Klenerman P
J Virol; 1999 May; 73(5):4120-6. PubMed ID: 10196308
[TBL] [Abstract][Full Text] [Related]
14. Unmethylated CpG-containing oligodeoxynucleotides inhibit apoptosis in WEHI 231 B lymphocytes induced by several agents: evidence for blockade of apoptosis at a distal signalling step.
Macfarlane DE; Manzel L; Krieg AM
Immunology; 1997 Aug; 91(4):586-93. PubMed ID: 9378499
[TBL] [Abstract][Full Text] [Related]
15. CpG oligodeoxynucleotide prolongs eosinophil survival through activation of contaminating B cells and plasmacytoid dendritic cells in vitro.
Matsumoto K; Terakawa M; Fukuda S; Kato A; Toki S; Shinohara M; Wakiguchi H; Saito H
Int Arch Allergy Immunol; 2006; 140 Suppl 1():42-50. PubMed ID: 16772726
[TBL] [Abstract][Full Text] [Related]
16. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry.
Yi AK; Chang M; Peckham DW; Krieg AM; Ashman RF
J Immunol; 1998 Jun; 160(12):5898-906. PubMed ID: 9637502
[TBL] [Abstract][Full Text] [Related]
17. Immunostimulatory CpG-oligodeoxynucleotides induce a factor that inhibits macrophage adhesion.
Macfarlane DE; Manzel L
J Lab Clin Med; 1999 Nov; 134(5):501-9. PubMed ID: 10560944
[TBL] [Abstract][Full Text] [Related]
18. Non-CpG Oligonucleotides Exert Adjuvant Effects by Enhancing Cognate B Cell-T Cell Interactions, Leading to B Cell Activation, Differentiation, and Isotype Switching.
Herbáth M; Papp K; Erdei A; Prechl J
J Immunol Res; 2015; 2015():340468. PubMed ID: 26380319
[TBL] [Abstract][Full Text] [Related]
19. Subcellular localization as a limiting factor for utilization of decoy oligonucleotides.
Bene A; Kurten RC; Chambers TC
Nucleic Acids Res; 2004 Oct; 32(19):e142. PubMed ID: 15498923
[TBL] [Abstract][Full Text] [Related]
20. Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release.
Hong Z; Jiang Z; Liangxi W; Guofu D; Ping L; Yongling L; Wendong P; Minghai W
Int Immunopharmacol; 2004 Feb; 4(2):223-34. PubMed ID: 14996414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
